Source: Eur Respir J 2011; 38: 1368-1373
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nardi A., Brillet P-Y., Letoumelin P., Girard F., Brauner M., Uzunhan Y., Naccache J-M., Valeyre D., Nunes H.. Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J 2011; 38: 1368-1373

Member's Comments

No comment yet.

Related content which might interest you: Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study Source: Eur Respir J 2012; 40: 101-109 Year: 2012 Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines Source: Eur Respir J 2003; 22: Suppl. 45, 578s Year: 2003 The use of symbicort in the treatment of patients with I and II stages of pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 85s Year: 2007 Respiratory function in stage II pulmonary sarcoidosis patients Source: Eur Respir J 2001; 18: Suppl. 33, 385s Year: 2001 Prevalence and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early stage of COPD Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Predictors of major serious manifestations in the terminal stage of lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 Standardised mortality rates in females and males with COPD and asthma Source: Eur Respir J 2005; 25: 891-895 Year: 2005 COPD coronary/peripheral vascular disease Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Source: Eur Respir J 2011; 37: 356 Year: 2011 Analysis of long-term survival of patients diagnosed of pulmonary embolism (PE) Source: Annual Congress 2006 - Pulmonary embolism Year: 2006 Lung cancer in patient with chronic obstructive pulmonary disease (comorbidity by smokers-a cumulative effect of exogenic and endogenic factors? Part II) Source: Annual Congress 2013 –COPD treatment Year: 2013 Is the COPD-index a significant prognostic factor of functional results of lobectomy in COPD patients? Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007 Physician-diagnosed COPD GOLD stage IV in Östersund, Sweden: prevalence and patient characteristics Source: Eur Respir J 2006; 28: Suppl. 50, 447s Year: 2006 Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype Source: Annual Congress 2013 –COPD treatment Year: 2013 Long-term follow-up of the ISOLDE participants: causes of death after 13 years of the trial completion Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer Year: 2007 A retrospective analysis of risk factors for Durvalumab related interstitial lung disease after chemoradiotherapy in Stage III NSCLC Source: Virtual Congress 2020 – Localised non-small cell lung cancer Year: 2020 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Determinants of success Source: Eur Respir J 2011; 38: 1215-1218 Year: 2011 Mortality in COPD: role of comorbidities Source: Eur Respir J 2006; 28: 1245-1257 Year: 2006 Comorbidities in stage IV COPD patients Source: Annual Congress 2011 - COPD management Year: 2011